CAJ | 학술논문

目的探讨全聋型突发性聋的药物治疗.方法采用前瞻性临床多中心、随机、单盲法研究,纳入年龄18 ～ 65周岁,病程2周内,未经任何相关医疗处理的全聋型突发性聋患者(纯音测听全部频率听阈升高,500、1000、2000、4000 Hz平均听阈≥81 dB HL).按各分中心随机数字表,随机选取四种治疗方案(巴曲酶,巴曲酶+银杏叶提取物,巴曲酶+银杏叶提取物+糖皮质激素和银杏叶提取物+糖皮质激素)中的一种对患者进行治疗.结果 2007年8月至2011年10月,全国33家医院按标准共纳入符合条件的单侧全聋型突发性聋276例,其中男135例(48.91％),女141例(51.09％)；平均年龄(41.7±13.3)岁.治疗后,听力痊愈40例(14.49％),显效78例(28.26％),有效76例(27.54％),无效82例(29.71％),总有效率为70.29％.四种治疗方案中,总有效率分别为73.33％、61.43％、78.31％和67.95％,组间比较差异无统计学意义(x2=9.97,P=0.62).四组中耳聋痊愈率分别为11.11％、12.86％、16.87％和15.38％,使用激素的两组好于未使用者.全聋型突发性聋患者中耳鸣伴发率为92.39％,晕(头晕或眩晕)伴发率为44.93％,耳闷伴发率为50.36％；这些伴发症状的疗效在四种治疗方案中,组间差异无统计学意义(P值均＞0.05).结论全聋型突发性聋患者听力损失重,治疗有效率达70％,值得积极治疗；但痊愈率仅14％,医患对此应有合理预期.激素对提高耳聋痊愈率可能有一定作用,推荐使用.
목적 탐토전롱형돌발성롱적약물치료.방법 채용전첨성림상다중심、수궤、단맹법연구,납입년령18 ～ 65주세,병정2주내,미경임하상관의료처리적전롱형돌발성롱환자(순음측은전부빈솔은역승고,500、1000、2000、4000 Hz평균은역≥81 dB HL).안각분중심수궤수자표,수궤선취사충치료방안(파곡매,파곡매+은행협제취물,파곡매+은행협제취물+당피질격소화은행협제취물+당피질격소)중적일충대환자진행치료.결과 2007년8월지2011년10월,전국33가의원안표준공납입부합조건적단측전롱형돌발성롱276례,기중남135례(48.91％),녀141례(51.09％)；평균년령(41.7±13.3)세.치료후,은력전유40례(14.49％),현효78례(28.26％),유효76례(27.54％),무효82례(29.71％),총유효솔위70.29％.사충치료방안중,총유효솔분별위73.33％、61.43％、78.31％화67.95％,조간비교차이무통계학의의(x2=9.97,P=0.62).사조중이롱전유솔분별위11.11％、12.86％、16.87％화15.38％,사용격소적량조호우미사용자.전롱형돌발성롱환자중이명반발솔위92.39％,훈(두훈혹현훈)반발솔위44.93％,이민반발솔위50.36％；저사반발증상적료효재사충치료방안중,조간차이무통계학의의(P치균＞0.05).결론 전롱형돌발성롱환자은력손실중,치료유효솔체70％,치득적겁치료；단전유솔부14％,의환대차응유합리예기.격소대제고이롱전유솔가능유일정작용,추천사용.
Objective To assess the results of drug therapy in patients with severe idiopathic sudden sensorineural hearing loss (ISSHL) with total frequency hearing loss.Methods A prospective randomized,single blind,multi-center clinical trial was designed.The untreated patients with ISSHL were included,who had severe hearing loss (pure tone audiometry showed patients had total frequency hearing loss,and their mean auditory threshold of 500,1000,2000,4000 Hz was beyond 81 dB HL),age between 18 to 65 years old,and within 14 days of the onset.The patients were divided into one of the four drug groups [batroxobin,batroxobin + ginkgo biloba leaves extract (EGb),batroxobin + EGb + glucocorticoids,EGb + glucocorticoids] according to the random table,and receive treatment.Results Totally 276 patients with unilateral severe ISSHL were included from 33 hospitals,from August 2007 to October 2011.Among them,male patients accounted for 135 (48.91％),female 141 (51.09％) ; the average age was (41.7 ± 13.3)years.Forty cases were recovered (14.49％),78 cases had marked effective (28.26％),76cases were effective (27.54％),82 cases were in-effective (29.71％),and the total effective rate was 70.29％.Among four drug groups,the separate effective rate were 73.33％,61.43％,78.31％ and 67.95 ％ respectively,no significant difference was found between groups (x2 =9.97,P =0.62).Among the four groups,the separate cure rate for hearing loss were 11.11％,12.86％,16.87％ and 15.38％,the glucocorticoid groups were significantly better than those not used.Among severe sudden deafness patients,92.39％ cases accompanied with tinnitus,44.93％ with dizziness (or vertigo),50.36％ with ear stuffy.There had no significant difference between the four groups with accompanied symptoms (all P ＞ 0.05).Conclusions It is value to give active treatment to sever sudden deafness patients because of an effective rate of 70％.However,the doctors and patients should be mind of a cure rate of only 14％.Steroids are recommended bacause it may play a role in the improvement rate.